Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.

od Taskinen, M R, Bogardus, C, Kennedy, A, Howard, B V
Wydane 1985

Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids

od Vehmanen, L, Saarto, T, Blomqvist, C, Taskinen, M-R, Elomaa, I
Wydane 2004

Characterization of lipase activities in obese Pima indians. Decreases with weight reduction.

od Reitman, J S, Kosmakos, F C, Howard, B V, Taskinen, M R, Kuusi, T, Nikkila, E A
Wydane 1982

Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment

od Groop, P-H, Del Prato, S, Taskinen, M-R, Owens, D R, Gong, Y, Crowe, S, Patel, S, von Eynatten, M, Woerle, H-J
Wydane w Diabetes Obes Metab (2014)

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

od Tahvanainen, E, Syvanne, M, Frick, M H, Murtomaki-Repo, S, Antikainen, M, Kesaniemi, Y A, Kauma, H, Pasternak, A, Taskinen, M R, Ehnholm, C
Wydane 1998

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics

od Björnson, E., Packard, C. J., Adiels, M., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Sihlbom, C., Thorsell, A., Zhou, H., Taskinen, M.‐R., Borén, J.
Wydane w J Intern Med (2019)

Metabolic effects of liver transplantation in cirrhotic patients.

od Luzi, L, Perseghin, G, Regalia, E, Sereni, L P, Battezzati, A, Baratti, D, Bianchi, E, Terruzzi, I, Hilden, H, Groop, L C, Pulvirenti, A, Taskinen, M R, Gennari, L, Mazzaferro, V
Wydane 1997

Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B...

od Pajukanta, P, Terwilliger, J D, Perola, M, Hiekkalinna, T, Nuotio, I, Ellonen, P, Parkkonen, M, Hartiala, J, Ylitalo, K, Pihlajamäki, J, Porkka, K, Laakso, M, Viikari, J, Ehnholm, C, Taskinen, M R, Peltonen, L
Wydane 1999

Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.

od Lehto, M, Tuomi, T, Mahtani, M M, Widén, E, Forsblom, C, Sarelin, L, Gullström, M, Isomaa, B, Lehtovirta, M, Hyrkkö, A, Kanninen, T, Orho, M, Manley, S, Turner, R C, Brettin, T, Kirby, A, Thomas, J, Duyk, G, Lander, E, Taskinen, M R, Groop, L
Wydane 1997